NCT02706184 - E. Coli Nissle in Oncology | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Gastric CancerColorectal Cancer

Interventions

DRUG

E. coli Nissle suspension

Patients receive E. coli Nissle suspension

DRUG

Placebo

Trial Locations (5)

Klinikum Stuttgart, Stuttgart

Klinikum Stuttgart, Stuttgart

Klinikum Ludwigsburg, Ludwigsburg

Klinikum am Steinenberg /Ermstalklinik, Reutlingen

Paracelsus-Krankenhaus Ruit, Ostfildern

All Listed Sponsors

collaborator

Ardeypharm GmbH

INDUSTRY

lead

University of Hohenheim

OTHER